Skip to Content

Moneyline: PharMerica, FOSRx make buys

Moneyline: PharMerica, FOSRx make buys

LOUISVILLE, Ky. - Amerita, the Specialty Infusion Division of PharMerica, has acquired Fairlawn, N.J.-based Nextron, a provider of certain specialty medications in the home. The move allows Amerita to further its expansion in the eastern United States.

“This expansion is consistent with our strategy to become a national home infusion provider,” said Greg Weishar, PharMerica's CEO, in a press release.

Paragon Ventures served as adviser to Nextron. Terms of the deal were not disclosed.

FOSRx closes deal

CUMBERLAND, Md. - Factor One Source Pharmacy has acquired Metairie, La.-based Fast Access Specialty Therapeutics. Together the two companies generated approximately $136 million dollars in revenue in 2016 and are projected to generate $156 million in revenue for 2017.

Sajal Roy, CEO of FOSRx, will become CEO of the combined companies.

FAST, which has 42 employees and annual revenue of nearly $100 million, will retain its brand but operate under the FOSRx umbrella.

Paragon Ventures served as adviser to Nextron. Terms of the deal were not disclosed.

Comments

To comment on this post, please log in to your account or set up an account now.